Keyphrases
Alzheimer's Disease
100%
Apolipoprotein E
93%
Dementia Risk
77%
Dementia
70%
Adjusted Hazard Ratio
45%
ApoE
38%
Complement C3
38%
Meta-analysis
38%
General Population Sample
36%
Prospective Cohort Study
36%
Absolute Risk
33%
Cardiovascular Risk
32%
Risk Map
29%
General Population Studies
28%
Copenhagen
27%
Dietary Guidelines
26%
Rare Variants
25%
Confidence Interval
25%
Blood Pressure Regulation
24%
Alzheimer's Dementia
24%
Age-related Macular Degeneration
22%
Vascular Dementia
21%
Copenhagen City Heart Study
19%
Mendelian Randomization
18%
Vascular Disease
17%
Genotype
17%
High Risk
15%
Alzheimer's Disease Pathology
14%
Genetic Variation
14%
APOE Genotype
14%
Plasma Parameters
14%
Genetic Studies
14%
Low Adherence
13%
Population Cohort Study
12%
RIN3
12%
CD2AP
12%
Telomere Dysfunction
12%
Ischemic Vascular Disease
12%
Primary Prevention
12%
PICALM
12%
Absolute Cardiovascular Risk
12%
Misclassification
12%
Diabetic
12%
Immature Granulocytes
12%
Aortic Valve Stenosis
12%
BIN1
12%
Neutrophils
12%
Dyslipidemia
12%
Population-based Cohort Study
12%
Stroke Risk
12%
Biochemistry, Genetics and Molecular Biology
Apolipoprotein E
83%
Population
81%
Genotyping
68%
Cohort Study
62%
Allele
41%
Complement Component 3
40%
Prospective Cohort Study
36%
Genetics
32%
Population Research
25%
Blood Pressure Regulation
24%
Mendelian Randomization
20%
Amyloid
18%
Lipid
16%
Blood Level
15%
Genetic Variation
14%
Clusterin
12%
Partial Thromboplastin Time
12%
Lipid Profile
12%
Physical Activity
12%
Telomere
12%
Cancer Mortality
12%
Transcytosis
12%
Cardiovascular Mortality
12%
Granulocyte
12%
Missense
12%
Blood Brain Barrier
12%
Blood Pressure
12%
Genetic Divergence
11%
Physical Inactivity
10%
BIN1
9%
All Cause Mortality
9%
CD2AP
9%
PICALM
9%
Genome-Wide Association Study
8%
Wnt Signaling Pathway
8%
Lipoprotein
7%
Triacylglycerol Blood Level
6%
Telomere Length
6%
HDL-Cholesterol
6%
Low-Density Lipoprotein
6%